[1]
Akef, A. et al. 2026. Impact of Molecular and Cytogenetic Risk Stratification, Early Treatment Response, and Inflammatory Biomarkers on Survival in Intensively Treated Non-Acute Promyelocytic Leukemia Acute Myeloid Leukemia. World Journal of Oncology. 17, 6 (Jan. 2026), 886–897. DOI:https://doi.org/10.14740/wjon2856.